Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 31;6(1):29.
doi: 10.1038/s41540-020-00143-9.

A global network for network medicine

Collaborators, Affiliations

A global network for network medicine

Bradley A Maron et al. NPJ Syst Biol Appl. .

Abstract

Network Medicine is now an established scientific discipline, having generated key insights on integrated mechanisms underlying complex human diseases. The next discovery phase will emphasize innovating analytics that optimize networks for advancing precision medicine. Accomplishing this goal will require organizing a scientifically diverse team studying big datasets shared globally.

PubMed Disclaimer

Conflict of interest statement

B.A.M.: Consultant for Actelion Pharmaceuticals for a project unrelated to this current work; co-inventor on U.S. patent pending PCT/US2019/059890 and U.S. patent 9,605,047, which are not related to the current work. P.F.: Founder and CEO of Pharmahungary Group, a group of R&D companies. E.S.: In the past 3 years, he has received institutional grant support from GSK and Bayer. A.L.B.: is the founder of Scipher, Foodome and Nomix, companies that are using tools of network science to make an impact on health. J.L.: Co-founder of Scipher (for profit) Scientific Advisory Board (2013-to present), and consulting services. The remaining authors declare no competing interests.

References

    1. Barabási AL. Network medicine–from obesity to the “diseasome”. N. Engl. J. Med. 2007;57:404–407. doi: 10.1056/NEJMe078114. - DOI - PubMed
    1. Menche. J, et al. Disease networks. Uncovering disease-disease relationships through the incomplete interactome. Science. 2015;347:1257601. doi: 10.1126/science.1257601. - DOI - PMC - PubMed
    1. Halu A, et al. Exploring the cross-phenotype network region of disease modules reveals concordant and discordant pathways between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Hum. Mol. Genet. 2019;28:2352–2364. doi: 10.1093/hmg/ddz069. - DOI - PMC - PubMed
    1. Lee LY, Loscalzo J. Network medicine in pathobiology. Am. J. Pathol. 2019;189:1311–1326. doi: 10.1016/j.ajpath.2019.03.009. - DOI - PMC - PubMed
    1. Maron BJ, Maron MS, Maron BA, Loscalzo J. Moving beyond the sarcomere to explain heterogeneity in hypertrophic cardiomyopathy: JACC Review Topic of the Week. J. Am. Coll. Cardiol. 2019;73:1978–1986. doi: 10.1016/j.jacc.2019.01.061. - DOI - PMC - PubMed